
The deal is expected to be sealed at a valuation of $1 billion, after a highly competitive bid process that saw some of the largest buyout PE funds participate, people aware of the ongoing discussions told ET.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2JkO4Ha
via
IFTTT
0 comments:
Post a Comment